ICCC

NASDAQ 已收盘

ImmuCell Corporation

11.07 USD
-0.17+0.27%
2026-08-03
市值
$100.15M
市盈率
EPS
-0.07
股息率
52 周区间
4.52 – 12.10
成交量
27.58K
Beta
0.57
目标价
52W 低 4.5252W 高 12.10
价格走势

公司简介

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in the United States and internationally. It operates through two segments, Scours and Mastitis. The company offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. It also provides California Mast...